Accrued
expenses and other current liabilities consisted of the following:
Schedule of Accrued Expenses and Other Current Liabilities
| | |
2024 | | |
2025 | |
| | |
As of December 31, | |
| | |
2024 | | |
2025 | |
| | |
US$ | | |
US$ | |
| Accrued payroll and welfare | |
| - | | |
| 885,807 | |
| Accrued expenses (1) | |
| - | | |
| 276,095 | |
| Contingent consideration liability (2) | |
| - | | |
| 136,200 | |
| Advance from customers | |
| - | | |
| 39,096 | |
| Others | |
| - | | |
| 23,207 | |
| Total accrued expenses and other current liabilities | |
| - | | |
| 1,360,405 | |
| (1) | The
balance of accrued expenses represented accrued professional services and other miscellaneous
fees. |
| (2) | The
balance of contingent consideration represented the estimated fair value of Fundraising incentive
related to the acquisition of TEX and H2N. Refer to Note 3 - Acquisitions for further information
about the Group’s acquisition related transactions. |
|